.6 semaglutide Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo Medscape | Semaglutide (Wegovy) is

The increased risks of peripheral vestibular disorders, dizziness, and hearing impairment associated with GLP-1 RA use were generally consistent across most subgroups, except among participants of Black and Asian races

Are you interested in contributing to this newsletter or learning about the Chronicles services

Here are some of the common themes from positive reviews: The sign-up was straightforward and my medication arrived faster than I expected

Effect sizes were generally large, with treated animals showing substantial improvements in healing time, tissue strength, functional recovery, and histological outcomes compared to untreated controls